Latest filing published 26 Nov 2024 for AbCellera Biologics Inc., €145k. Read the official filing
Carl L. G. Hansen, listed as chief executive, appears in our data through filings on AbCellera Biologics Inc. shares, published by SEC (Form 4). In total, 14 filings cover trades dated from 9 June 2021 to 25 November 2024.
Every open-market trade on record is a sale: 1 sale worth €110.4M. Other entries cover 13 option exercises.
On 26 November 2024 came the latest disclosure, an option exercise for €145k in AbCellera Biologics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Thermopylae Holdings Ltd., counted once · View ↗
14 of 13 declarations